Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
February 4, 2026Angelini Pharma, CEO
Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …
QV Bioelectronics secures £4.5m in funding for brain cancer therapy development
February 3, 2026Research and Development Oncology, QV Bioelectronics, glioblastoma
QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
Alvotech appoints Lisa Graver as CEO
February 3, 2026Alvotech, CEO
Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …
HonorHealth Research Institute announces first patient dosed with new stroke treatment
February 2, 2026Research and Development HonorHealth Research Institute, Neurology, ischemic stroke
HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …
Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK
February 2, 2026Accord healthcare, Associate Vice President, Country Head
Accord Healthcare has announced the appointment of Paul Burden as Associate Vice President and Country Head of Accord UK. Burden …
Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases
January 30, 2026Medical Communications United Nations, WHO, healthcare access, mental health, noncommunicable diseases, primary care
The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental health challenges and noncommunicable diseases …
Rare diseases – spinal muscular atrophy
January 30, 2026Medical Communications gene therapy, medical communications, muscle and motor function, muscle weakness, rare diseases, sma
Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can lead to difficulties in activities …
Could targeting the molecular causes of infertility finally transform IVF success rates?
January 29, 2026Medical Communications, Research and Development Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility
By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …
Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
January 29, 2026Medical Communications MHRA, NHS, NICE, Wellcome, digital technologies, medical communications, mental health
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together with other forms of care, …
Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building
January 29, 2026Research and Development Barts Health NHS Trust, H.I.G. Realty, health innovation
Barts Health NHS Trust and H.I.G. Realty have announced a collaboration to launch an applied healthcare innovation building in the …
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US
January 29, 2026Head of Business Development US, Rentschler Biopharma
Rentschler Biopharma has announced the appointment of Detra Glinatsis as Head of Business Development US. Glinatsis brings more than two …
Five Facts about spinal muscular atrophy
January 28, 2026Medical Communications Five Facts, Neurology, early diagnosis, five types, gene therapy, muscle weakness, spinal muscular atrophy
1 Spinal muscular atrophy (SMA) is a genetic disease involving the loss of motor neurons in the spinal cord.1 Its …
Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases
January 28, 2026Aspaveli, European Commission, Nephrology, sobi
Sobi has announced that its Aspaveli (pegcetacoplan) has received approval from the European Commission (EC) for the treatment of two …
Everdrone appoints David Borkmann as Senior Medical Advisor
January 28, 2026Everdrone, senior medical advisor
Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has announced the appointment of David …
MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance
January 27, 2026FDA, Gastrointestinal tract, MRM Health, ulcerative colitis
Microbial Resource Management (MRM) Health has announced that its lead programme, MH002, has received Investigational New Drug (IND) clearance from …
Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer
January 27, 2026Crystalys Therapeutics, chief financial officer
Crystalys Therapeutics has announced the appointment of Justin Thacker as Chief Financial Officer (CFO). Thacker has spent over 20 years …
Rentschler Biopharma appoints Uwe Buecheler as interim CEO
January 26, 2026Rentschler Biopharma, interim CEO
Rentschler Biopharma, a contract development and manufacturing organisation (CDMO) specialising in biopharmaceutical products, has announced the appointment of Uwe Buecheler …
Sandoz’ Ondibta receives European Commission approval for diabetes
January 26, 2026Research and Development Diabetes, Ondibta, Sandoz
Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
January 22, 2026Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy
Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …
PSI appoints David Allen as Country Manager for Canada
January 22, 2026Country Manager for Canada, PSI
PSI, a contract research organisation (CRO) with a focus on clinical trial delivery, has announced the appointment of David Allen …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
